subject: Stem Cell Therapies: Advanced-stage Clinical Trials-aarkstore Enterprise [print this page] Presently, there are over 160 stem cell-based therapeutic products undergoing development for the treatment of various diseases, including cardiac, immune, neurodegenerative, ophthalmic and peripheral artery diseases, diabetes, spinal cord injury and stroke, as well as for some other indications.
Although majority of products in development are in preclinical stage, 27 products are in Phase II and III clinical stage.
Market research report Stem Cell Therapies: Advanced-Stage Clinical Trials features detailed profiles of all 27 products, including indications, state and stage of development, clinical trials details with primary and secondary outcome measures and time frames (start and estimated completion of clinical trials), product characteristics and mechanism of action, underlying technologies, results of clinical trials (if available), product origin, developing and co-developing companies and cooperation agreements.
Out of 27 analyzed products, the majority of products (59%) are in Phase II clinical trials, 7 products are in Phase III and 4 are in Phase II/III. For one product, after completed Phase III clinical trial, expanded access is available. Total of 11 clinical trials are expected to be completed in 2010. One company even expects that its R & D product may be approved by the end of 2010.
